Chakraborty, KaustavNeogi, RajarshiBasu, Debasish2011-12-072011-12-072011-06Chakraborty Kaustav, Neogi Rajarshi, Basu Debasish. Club drugs: review of the ‘rave’ with a note of concern for the Indian scenario. Indian Journal of Medical Research. 2011 June; 133(6): 594-604.http://imsear.searo.who.int/handle/123456789/135702'Club drugs’ which include Ecstasy, gamma-hydroxybutyrate (GHB), ketamine, and Rohypnol (flunitrazepam) have become popular with participants in ‘raves’, because they are perceived to enhance energy, endurance, sociability and sexual arousal. These drugs vary in their pharmacologic properties, physiological and psychological effects, and potential consequences. The use of club drugs by young people has increased in the last decade, and continue to get modified and evolve, making them very difficult to monitor. Further, these drugs are not picked up by routine drugs screening procedures, thereby making these popular with the criminals. India, which is in a phase of social transition, also faces this rising menace. Despite the nature and extent of this problem, this area has been under-researched. Data from India are sparse barring a few newspaper and police reports. Keeping abreast of current trends in club drug use prepares the clinician to recognize the clinical effects of club drug use, to manage club drug related emergencies, and to generate social awareness.enClub drugsEcstasygamma-hydroxybutyrateketaminerave drugsrohypnolAnesthetics, Dissociative --adverse effectsAnti-Anxiety Agents --adverse effectsDesigner Drugs --adverse effectsFlunitrazepam --adverse effectsHallucinogens --adverse effectsHumansIndiaKetamine --adverse effectsN-Methyl-3,4-methylenedioxyamphetamine --adverse effectsPsychotropic Drugs --adverse effectsSocial BehaviorStreet Drugs --adverse effectsSubstance-Related DisordersArticle